St. Jude Medical, Inc. (NYSE:STJ)

Cheap stock.

Medical equipment -- primarily coronary -- is only going to be a growth industry for at least the next five years. Solid financials, good net income.

12/13

I have an implant in my neck,after 4 yrs of surguries it did what they said,there goal was to releive pain and get me off medicines by 40 to 50% because there is no cure for what i have.I have it for 1 yr now and i am much better off than I was,so I bought 100 shares at 38.78 because it worked like they said,I hope the stock goes up,but I bought it because it helped,I had several opinions from sever neuro surgens and they all said go with stj above the rest they all said it was much better than other med devices.I was in houston med center and I still hurt and have to take strong meds but not like before.So my moral to this is sentimental but I wanted to thank them ,and indirectly this is how I did,just be careful and do not break your neck but they are no 1 in my book,so it is what it is,I just hope there stock goes up so they can help more people and they can spend more in R@D and help others,and I could use the change in my pocket even though I have someone get it out of my pocket for me.

As stated by others, the ICD market is growing, but at a MUCH slower pace than anticipated a few years ago and average sales prices are dropping rapidly. More importantly, one of STJ's ICD leads, Riata, will likely end up being recalled by the FDA soon. ICD's make up a very large percentage of STJ's total revenue. Studies have begun to be published showing a structural failure rate around 15%. A recall could have a major impact (patient safety issues, law suits, loss of credibility with doctors, etc). Although STJ now sells a modified version of the Riata marketed under the name Durata, the modified lead appears to have the same basic design as the Riata. If a recall of the Riata occurs, Durata COULD be right behind it. That would leave St. Jude without an FDA approved ICD lead...and in big trouble.

6F defib leads quality concerns.

Here's the buy rec:
http://www.fool.com/investing/general/2011/07/25/rising-star-buy-st-jude-medical.aspx

Rising Star Buy: http://www.fool.com/investing/general/2011/07/25/rising-star-buy-st-jude-medical.aspx

Found this from my stock screener.

1x - 4/1

From relative pe screen. My price target 52.02

Demographics around the world indicate a growing population over the age of 65 in developed countries and a richer, broader middle class in emerging markets. The demand for healthcare and heart-related equipment/supplies will rise substantially year over year for the next two decades. St. Jude's, as well as, MDT and BSX, big pharm, other health-care suppliers are the right businesses at the right time. They have to be really badly managed to screw this up.

http://caps.fool.com/Blogs/ViewPost.aspx?bpid=350402&t=01001644285823293180

Growing revenue and profit, and an insider made a large purchase recently.

More people will get medical help

Life-saving devices that target heart disease. Higher than expected Q3 sales, and well insulated from macro turmoil.

Mad Money

Great entry point

medical stocks eem to do well in the current marketenviornment. Stocks down medical stocks up. Baby Boomers aren't getting any younger and still want to live forever!